3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Monday, June 05
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Monday, June 05 based on AAII’s Stock Grades.Jack Gilleland
Stock Evaluator: Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. VVOS
$0.18
0.00
1.32%
September 11, 2026 4:00:00 PM
EST
Volume: 1,476,557
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Commentary & Analysis
4 Undervalued Medical Equipment, Supplies & Distribution Stocks for Wednesday, May 03
Discover the top 4 undervalued Medical Equipment, Supplies & Distribution stocks for Wednesday, May 03 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Monday, April 03
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Monday, April 03 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Thursday, March 02
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Thursday, March 02 based on AAII’s Stock Grades.Jack Gilleland
Is Vivos Therapeutics Inc (VVOS) Stock a Good Investment?
Learn more about Vivos Therapeutics Inc's (VVOS) stock grades for Value, Momentum and Growth and determine whether this Medical Equipment, Supplies & Distribution stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | VVOS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.7 | $1,872.1 | 2% |
|
| Shares Out (Mil) | 17.7 | 76.7 | 28% |
|
| Institutional Ownership | 77.2% | 87.8% | 47% |
|
| Float (Mil) | 19.1 | 56.5 | 28% |
|
| Beta | 6.09 | 0.74 | 100% |
|
| Avg Daily Volume (000s) | 62,686 | 526 | 100% |
|
| Price Change (52-week) |
(95.2%) | 79.8% | 3% |
|
| Growth | VVOS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 5.8% | 10.4% | 40% |
|
| Net Income (5yr) | (11.9%) | (0.2%) | 27% |
|
| EPS (5yr) | 43.2% | 3.0% | 90 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.0%) | (17.9%) | 52% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 3 | |
| Current EPS | ($0.303) | ($1.343) | ($0.823) | |
| Month Ago EPS | ($0.303) | ($1.393) | ($0.790) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.420) | ($1.820) | ($0.840) | |
| Year/Year Chg | (2.3%) | (34.8%) | na | |
| Financials | VVOS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $21 | $1,504 | 13% |
|
| Net Income (TTM) (Mil) | ($26) | $28 | 22% |
|
| EPS (TTM) | ($1.827) | $0.200 | 15% |
|
| Operating Cash Flow (TTM) (Mil) | ($17) | $162 | 16% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | $8 | 37% |
|
| Long-Term Debt (Q1) (Mil) | $4 | $373 | 23% |
|
| Enterprise Value (Q1) (Mil) | $18 | $2,343 | 10% |
|
| Valuation | VVOS | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.88 | na |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VVOS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 61.9% | 27.8% | 74% |
|
| Net Margin | (121.8%) | 1.3% | 7% |
|
| ROA | (101.5%) | 2.2% | 5% |
|
| ROE | na | 7.2% | na |
|
| Liabilities to Assets | 116.5% | 60.5% | 96% |
|
| F-Score | 4 | 5 | 33% |
|
Vivos Therapeutics, Inc. did not pass any screens on 9/11/2026.
